Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2024(Status and Outlook)

Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Research Report 2024(Status and Outlook)



Report Overview:

Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.

The Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size was estimated at USD 527.50 million in 2023 and is projected to reach USD 637.24 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.

This report provides a deep insight into the global Pharmaceutical Grade Nicotinamide Mononucleotide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Grade Nicotinamide Mononucleotide Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Grade Nicotinamide Mononucleotide market in any manner.

Global Pharmaceutical Grade Nicotinamide Mononucleotide Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GeneHarbor

Herbalmax

Shinkowa

EffePharm

Mirailab Bioscience

Bangtai Bio

Jindawei

Hongboyuan Life Technology

Market Segmentation (by Type)

Concentration≥98%

Concentration<98%

Market Segmentation (by Application)

Health Products

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Pharmaceutical Grade Nicotinamide Mononucleotide Market

Overview of the regional outlook of the Pharmaceutical Grade Nicotinamide Mononucleotide Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Grade Nicotinamide Mononucleotide Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical Grade Nicotinamide Mononucleotide
1.2 Key Market Segments
1.2.1 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Type
1.2.2 Pharmaceutical Grade Nicotinamide Mononucleotide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical Grade Nicotinamide Mononucleotide Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Landscape
3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Grade Nicotinamide Mononucleotide Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends
3.6.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical Grade Nicotinamide Mononucleotide Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical Grade Nicotinamide Mononucleotide Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2019-2024)
7 Pharmaceutical Grade Nicotinamide Mononucleotide Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
8 Pharmaceutical Grade Nicotinamide Mononucleotide Market Segmentation by Region
8.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Grade Nicotinamide Mononucleotide Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GeneHarbor
9.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.1.4 GeneHarbor Business Overview
9.1.5 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.1.6 GeneHarbor Recent Developments
9.2 Herbalmax
9.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.2.4 Herbalmax Business Overview
9.2.5 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.2.6 Herbalmax Recent Developments
9.3 Shinkowa
9.3.1 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.3.2 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.3.3 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.3.4 Shinkowa Pharmaceutical Grade Nicotinamide Mononucleotide SWOT Analysis
9.3.5 Shinkowa Business Overview
9.3.6 Shinkowa Recent Developments
9.4 EffePharm
9.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.4.4 EffePharm Business Overview
9.4.5 EffePharm Recent Developments
9.5 Mirailab Bioscience
9.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.5.4 Mirailab Bioscience Business Overview
9.5.5 Mirailab Bioscience Recent Developments
9.6 Bangtai Bio
9.6.1 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.6.2 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.6.3 Bangtai Bio Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.6.4 Bangtai Bio Business Overview
9.6.5 Bangtai Bio Recent Developments
9.7 Jindawei
9.7.1 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.7.2 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.7.3 Jindawei Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.7.4 Jindawei Business Overview
9.7.5 Jindawei Recent Developments
9.8 Hongboyuan Life Technology
9.8.1 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Basic Information
9.8.2 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Overview
9.8.3 Hongboyuan Life Technology Pharmaceutical Grade Nicotinamide Mononucleotide Product Market Performance
9.8.4 Hongboyuan Life Technology Business Overview
9.8.5 Hongboyuan Life Technology Recent Developments
10 Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Region
10.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast
10.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Region
10.2.4 South America Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2025-2030)
11.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application
11.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings